MORGANTOWN, W.Va., June 30, 2005 (PRIMEZONE) -- Protea Biosciences, Inc., a leader in the development of new protein separations technology, today announced the launch of new protein identification services for the biotechnology and pharmaceutical research industry.
The new services offer improved capability to identify proteins in complex mixtures and generate protein databases, including the full-scale analysis of protein samples and the generation of protein databases, organized and retrievable in user-friendly formats.
Protea's services utilize new, proprietary protein separation technology that improves on the current state-of-the-art.
"We utilize the very latest instrumentation, which, when combined with our own protein separation technology, allows us to generate the highest quality protein identification data -- rapidly and reproducibly," stated Matthew Powell, Ph.D., manager of Protea's Protein Research Laboratory. "Our laboratory focuses on developing more robust techniques for protein characterization and identification, and offers these to the biotechnology and pharmaceutical industry."
"We focus on biopharmaceutical companies who need reproducible data with rapid turnaround for the identification of proteins in complex mixtures. This is a major challenge for companies engaged in protein-based, pharmaceutical development," commented Steve Turner, Protea's chief executive officer. "Our goal is to advance the state-of-the-art, to provide rapid and reproducible protein identification capability to support their development programs."
Protea Biosciences, Inc. (www.proteabio.com) develops new technologies for improved protein separation and identification and provides products and services for protein identification to the pharmaceutical, biotechnology, and academic research communities.